Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Diagnosis and 10-year follow-up of a community-based hepatitis C cohort.

Yawn BP, Wollan P, Gazzuola L, Kim WR.

J Fam Pract. 2002 Feb;51(2):135-40.

PMID:
11978211
2.

Development and maintenance of a community-based hepatitis C registry.

Yawn BP, Gazzuola L, Wollan PC, Kim WR.

Am J Manag Care. 2002 Mar;8(3):253-61.

3.
4.

Outcomes of a Hepatitis C screening program at a large urban VA medical center.

Groom H, Dieperink E, Nelson DB, Garrard J, Johnson JR, Ewing SL, Stockley H, Durfee J, Jonk Y, Willenbring ML, Ho SB.

J Clin Gastroenterol. 2008 Jan;42(1):97-106.

PMID:
18097298
5.

Identification, evaluation, and management of obesity in an academic primary care center.

O'Brien SH, Holubkov R, Reis EC.

Pediatrics. 2004 Aug;114(2):e154-9.

PMID:
15286251
6.

Dental screening and referral of young children by pediatric primary care providers.

dela Cruz GG, Rozier RG, Slade G.

Pediatrics. 2004 Nov;114(5):e642-52.

PMID:
15520094
7.

Diagnosis and care of irritable bowel syndrome in a community-based population.

Yawn BP, Locke GR 3rd, Lydick E, Wollan PC, Bertram SL, Kurland MJ.

Am J Manag Care. 2001 Jun;7(6):585-92.

8.

Chronic hepatitis B and C infection in children in New South Wales.

Nightingale S, Stormon MO, Day AS, Webber MT, Ward KA, O'Loughlin EV.

Med J Aust. 2009 Jun 15;190(12):670-3.

PMID:
19527200
9.

Outcome of screening for hepatitis C virus infection based on risk factors.

Mallette C, Flynn MA, Promrat K.

Am J Gastroenterol. 2008 Jan;103(1):131-7. Epub 2007 Sep 25.

PMID:
17894850
10.

Four-year survival of transfusion recipients identified by hepatitis C lookback.

Vamvakas EC, Goldstein R.

Transfusion. 2002 Jun;42(6):691-7.

PMID:
12147020
11.
13.

[Incidence of hepatitis C in the Silesian voivodeship in the years 1997-2002].

Kowalska M, Zejda JE.

Przegl Epidemiol. 2004;58(3):435-44. Polish.

PMID:
15730007
14.

The impact of injecting drug use status on hepatitis C-related referral and treatment.

Stoové MA, Gifford SM, Dore GJ.

Drug Alcohol Depend. 2005 Jan 7;77(1):81-6.

PMID:
15607844
15.

Population-based hepatitis C surveillance and treatment in a national managed care organization.

Shatin D, Schech SD, Patel K, McHutchison JG.

Am J Manag Care. 2004 Apr;10(4):250-6.

16.

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Seeff LB, Hoofnagle JH.

Clin Liver Dis. 2003 Feb;7(1):261-87. Review.

PMID:
12691470
17.

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.

Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R.

Arch Intern Med. 2003 Jan 27;163(2):218-24.

PMID:
12546613
18.

Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum.

Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H.

Scand J Gastroenterol. 2003 Aug;38(8):864-70.

PMID:
12940441
19.

[Nosocomial risk factors of hepatitis C infection. A multicenter study in a hospital-based population].

Maugat S, Astagneau P, Thibault V, Desruennes E, Baffoy N, Desenclos JC, Brücker G.

Rev Epidemiol Sante Publique. 2003 Jun;51(3):301-8. French.

PMID:
13130210
20.

The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.

Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP.

Ophthalmology. 2008 Jan;115(1):169-73. doi: 10.1016/j.ophtha.2007.02.032.

PMID:
18166410

Supplemental Content

Support Center